important indicator of the strength and the
performance of our business as they provide a link to operating cash flow.
We also believe that analysts and investors use such measures to evaluate
the overall operating performance of companies in our industry, including
as a means of comparing period-to-period results and as a means of
evaluating our results with those of other companies.
Our non-GAAP operating performance improved from a loss of
approximately $0.6 million and $1 million, respectively, for the three and
six months ended September 30, 2007 to a (loss) gain of approximately
($98,000) and $8,000, respectively, for the three and six months ended
September 30, 2008. We attribute this improvement in non-GAAP operating
performance to the increase in sales and an improvement in gross margin
rate, offset partially by an increase in cash operating expenses.
Three Months Ended Six Months Ended
September 30, September 30,
2008 2007 2008 2007
Gross Profit
GAAP gross profit 3,371,317 $2,370,502 7,188,972 $4,724,964
% of sales 86% 78% 85% 79%
SFAS 123 (R)
share-based
compensation 8,879 9,107 25,253 9,686
Depreciation
expenses 13,057 13,054 25,847 28,604
Non-GAAP gross
profit 3,393,253 2,392,663 7,240,072 4,763,254
Operating Expenses
GAAP operating
expenses 3,962,936 3,755,494 8,238,179 $6,919,303
SFAS 123 (R)
share-based
compensation 198,131 494,449 464,748 660,956
Depreciation
expenses 62,104 46,379 119,161 78,159
Amortization
expenses 210,966
'/>"/>
SOURCE Uroplasty, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 Related medicine news :1.
Uroplasty to Present at the Noble Financial Fourth Annual Equity Conference2.
Uroplasty to Host First Quarter Conference Call on July 313.
Uroplasty Joins the Russell Microcap Index4.
Uroplasty Reports Record Growth for the Fourth Quarter and Fiscal Year 20085.
Uroplasty to Host Fourth Quarter and Year End Conference Call on June 36.
Uroplasty to Highlight Urgent PC System at American Urological Association 2008 Annual Meeting7.
Uroplasty Plans to Double Sales Force During Fiscal 20098.
Uroplasty, Inc. Reports Presentations of Urgent(R) PC Studies at the 2008 Society of Urologic Nurses and Associates Annual Symposium9.
Uroplasty to Present at ROTH Capital Partners 20th Annual OC Growth Stock Conference10.
Uroplasty Expands Marketing Program for Urology Practices11.
Uroplasty, Inc. Announces Pricing of a Public Offering of Its Common Stock